Stay updated on Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.

Latest updates to the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe record history now shows a new revision entry (v3.5.3) replacing the previous revision (v3.5.2), updating the study record's version history.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.5.2 was added to the history and Revision: v3.5.0 was removed.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedAdded revision v3.5.0 to the history and removed revision v3.4.3 from the record.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.3 was added to the history and Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.4.2 was added to the record history. Outdated notices including a funding-status warning and Revision: v3.4.1 were removed.SummaryDifference0.4%

- Check86 days agoChange DetectedAdded a site-wide notice regarding government funding and updated the page revision to v3.4.1, while the previous revision v3.4.0 was deleted. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sasanlimab in Non-muscle Invasive Bladder Cancer Clinical Trial page.